Acute Seizure Management in a Pediatric Cancer Patient Post-Chemotherapy and Right-Sided Radiotherapy
For a child experiencing seizures after completing chemotherapy and right-sided radiotherapy, immediately administer lorazepam 0.1 mg/kg IV (maximum 2 mg) for acute seizure control, followed by levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg), and urgently obtain brain MRI to evaluate for tumor progression, radiation-induced changes, or other structural complications. 1
Immediate Acute Seizure Management
Active Seizure Protocol
- Assess circulation, airway, and breathing (CAB) and provide airway protection, high-flow oxygen, and check blood glucose immediately 1
- For convulsive seizures:
- Transfer patient to pediatric intensive care unit 1
- Lorazepam 0.1 mg/kg IV (maximum 2 mg); repeat after at least 1 minute if needed (maximum 2 doses) 1
- Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) in addition to any maintenance dose 1
- If seizures persist, add phenobarbital IV loading dose 10-20 mg/kg (maximum 1,000 mg) 1
- Consider corticosteroids for cerebral edema 1
Post-Seizure Maintenance
- Maintenance dosing after seizure resolution:
Urgent Diagnostic Work-Up
Neuroimaging Priority
- Obtain contrast-enhanced brain MRI urgently as new-onset or worsening seizures in brain tumor patients often herald tumor progression 1
- MRI is superior to CT for detecting:
- Consider additional work-up including blood and CSF examination if clinically indicated 1
Electroencephalography (EEG)
- Obtain EEG to rule out nonconvulsive status epilepticus if there are worsening neurological symptoms or altered vigilance 1
- EEG helps distinguish epileptic seizures from psychogenic seizures 1
- Continuous EEG monitoring if seizures are refractory 1
Laboratory Evaluation
- Check for metabolic derangements, electrolyte abnormalities, and infection as potential seizure triggers 1, 2, 3
- Assess for chemotherapy-related complications 4, 5
Long-Term Antiepileptic Management
First-Line Medication Selection
Levetiracetam is the preferred first-choice antiepileptic drug for pediatric cancer patients due to efficacy, good tolerability, and lack of drug interactions with chemotherapy agents 1
Alternative Options
- Lamotrigine is an acceptable alternative with good antiseizure activity, though requires several weeks to reach therapeutic levels 1
- Valproic acid may be considered but requires monitoring for drug interactions and is contraindicated in females of childbearing potential 1
Medications to Avoid
Avoid enzyme-inducing anticonvulsants (phenytoin, phenobarbital, carbamazepine) due to significant drug interactions with steroids, chemotherapy, and targeted agents, plus unfavorable side-effect profiles 1, 5
Critical Clinical Considerations
Secondary Prophylaxis Indication
- All brain tumor patients who experience a seizure should receive secondary anticonvulsant prophylaxis until local tumor control is achieved 1
- Primary prophylaxis (before any seizure) is NOT indicated 1
Common Pitfalls
- Do not assume seizures are benign in this population—they frequently indicate tumor progression requiring immediate imaging 1
- Avoid prophylactic anticonvulsants in patients who have never seized, as they do not reduce first-seizure risk 1
- Monitor for psychiatric side-effects with levetiracetam, particularly in pediatric patients 1
- Check drug levels at follow-up to assess compliance and rule out drug-related side effects 1
Treatment-Related Seizure Etiologies
In this post-chemotherapy and radiotherapy context, consider:
- Radiation-induced changes including delayed leukoencephalopathy and radionecrosis 1
- Chemotherapy neurotoxicity, particularly from intrathecal methotrexate or L-asparaginase 4
- Tumor progression at the radiation site 1
- Metabolic complications from cancer treatment 2, 3